The unaddressed mechanistic foundation for FcRL1’s selective expression regulation among different neoplastic subtypes, along with the pathological implications of its expression dysregulation during tumor progression, highlight the necessity to systematically analyze the downstream transcriptional programs mediated by the FcRL1 receptor pathway. Here, FCRL1 is linked to neoplasm.